Category:
BIOTECHNOLOGY
Medical Device News Magazine reports breaking biotechnology news in addition to medical device news.
Immunexpress Presents Data on Clinical Validation of SeptiCyte® RAPID for Diagnosing Sepsis at e-ISICEM
Immunexpress notes the first poster, titled "Clinical Performance of a Rapid Sepsis Test on a Near-Patient Molecular Testing Platform," details the clinical validation of SeptiCyte® RAPID. The study compares Immunexpress' rapid version of the SeptiCyte® assay on the Biocartis Idylla™ platform to SeptiCyte® LAB in patients located in the U.S. and Europe.
Progentec Diagnostics Announces Launch of Novel Test That Anticipates Onset of Lupus-Related Flares
The aiSLE™ DX Flare Risk Index uses a set of blood-based biomarkers that are measurably altered before the onset of flare symptoms in patients with systemic lupus erythematosus.
Cernostics and Deciphex Strategic Collaboration – To Evaluate the Use of AI-Driven Image Analysis Tools and Technology to Improve Upon Early Detection of Cancer...
This collaboration combines the technological resources of both companies and will apply these to one of the world's largest cohorts of Barrett's esophagus patients with clinical outcome data, including patients who progressed to esophageal cancer.
Aegea Biotechnologies Advances to Semi-Finals of the $5M XPRIZE Rapid COVID Testing Competition
Aegea Biotechnologies notes XPRIZE is renowned for its worldwide competitions to solve humanity's most important challenges. The $5 million, XPRIZE Rapid COVID Testing competition was launched this summer to accelerate the development of high-quality COVID-19 testing that is affordable, easy to use, and that has a fast turnaround time.
ARUP Laboratories Now Offers COVID-19 Saliva Testing – Available with Preapproval to ARUP Clients Nationwide
ARUP Laboratories will perform the test only on saliva specimens collected using an ARUP collection kit with a healthcare provider present. ARUP validated the test using its kit on high-throughput instruments, and cannot perform it on other saliva specimens without jeopardizing quick turnaround times, said Adam Barker, Ph.D., director of ARUP's new COVID-19 Rapid Response Lab.
SafeSite Takes On COVID-19 with Protocol-Oriented Testing
SafeSite was formed by an assembly of medical professionals, all frustrated with the lack of cohesive and reliable COVID-19 testing procedures.
Vivera Pharmaceuticals Announces a New Diagnostic Test Solution For COVID-19
Access to reliable testing allows for better patient management and more informed public health decisions. By utilizing OmeCare's dedicated CLIA-certified and CAP-accredited facility, Vivera and OmeCare are helping to eliminate excessive wait times.
NeuroSense Therapeutics Announces Encouraging Interim Results of Clinical Study in ALS
The study, containing 15 patients, is scheduled to continue for an additional 6 months.
SQI Diagnostics Expanding Its Proprietary Rapid Diagnostic Testing Portfolio Targeting Organ Transplant, Autoimmune Disease and Serological Testing
SQI Diagnostics, Inc. CEO Mr. Robert L. Chioini stated, “Within our organ transplant, autoimmune disease, and serological testing business units we have multiple products in clinical development, and we believe these advanced tests have the potential to offer patients and consumers significant benefit once they receive regulatory approval.
